Global Collaboration in Retinoblastoma Care: Sheba Leads the Way
Pioneering Multidisciplinary Collaboration
In June 2024, Sheba hosted the inaugural Clinical-Radiological-Pathological Retinoblastoma-NET Multidisciplinary Team (MDT) session, marking a significant milestone in global retinoblastoma care. Led by Prof. Didi Fabian, Principal Investigator of the Global Retinoblastoma Study Group and Director of Sheba Global Ophthalmology, this groundbreaking virtual session brought together nearly 100 specialist physicians from around the world. The event aimed to enhance education, foster collaborative efforts, and explore innovative treatment approaches to advance global eye health, particularly in retinoblastoma care.
Case Discussions and Expert Insights
During the session, Prof. Fabian and his esteemed colleagues presented and discussed two intricate retinoblastoma cases, showcasing the power of international collaboration in addressing complex medical challenges. One particularly notable case involved a 3-year-old girl with unilateral leukocoria and complex retinoblastoma, requiring coordinated expertise from various specialists at Sheba.
The multidisciplinary team included Prof. Didi Fabian (Ocular Oncology), Dr. Shai Shrot (Neuro-Radiology), Dr. Jonathan Weidenfeld (Pathology), and Dr. Orit Rubinstein (Pediatric Oncology). Their combined efforts, spanning imaging assessments, pathology evaluations, and treatment strategies, underscored the critical role of teamwork in managing challenging cases. The session highlighted the importance of integrating diverse medical perspectives to achieve optimal patient outcomes.
Fostering Global Collaboration and Innovation
Following the detailed case presentations, a vibrant group discussion ensued among physicians from diverse specialties worldwide. This collaborative exchange enriched perspectives on the cases and promoted innovative approaches to retinoblastoma treatment. The session not only contributed to ongoing education and capacity-building efforts in global ophthalmology but also exemplified the power of international collaboration in advancing medical knowledge and practice.
Commitment to Excellence in Eye Care
At Sheba Global Ophthalmology, we remain dedicated to enhancing educational initiatives and fostering global partnerships to elevate standards of eye care worldwide. The inaugural Clinical-Radiological-Pathological Retinoblastoma-NET MDT session is a testament to our commitment to innovation, collaboration, and excellence in ophthalmology. By uniting experts from around the globe, we continue to push the boundaries of what is possible in retinoblastoma care, ensuring better outcomes for patients everywhere.
As we look to the future, Sheba will continue to lead the way in pioneering multidisciplinary approaches and fostering international collaboration, striving to make a lasting impact on global eye health.
More Posts
Sheba’s Physicians Sweep Forbes Israel’s 2025 “Best Doctors” List
Forbes Israel has named an exceptional number of Sheba Medical Center’s physicians on its 2025 “Best Doctors” list. Earlier this year, Sheba was ranked by Newsweek as one of the World’s Top 10 Hospitals. This recognition and alignment between institutional and individual excellence signals to the global medical community that Sheba concentrates many of Israel’s most trusted clinical leaders under one roof.
Twinning and Training: Scalable Solutions for Global Eye Cancer Equity
Sheba Global Ophthalmology (SGO) demonstrates how sustainable twinning and hands-on training create self-reliant ocular oncology capacity in low- and middle-income countries (LMICs), far surpassing the limitations of short-term outreach.
ARC Launches HaMeirim: Sheba’s New Cardiovascular Innovation Center
Sheba Medical Center’s ARC innovation arm has launched and inaugurated HaMeirim – ARC Cardiovascular (“The Radiant Ones” or “Those who shine”), a dedicated innovation center for the Heart, Thorax, and Vascular Center.
